Ärzteteam

Chérin P, Sedel F, Mignot C, Schüpbach M, Gourfinkel-An I, Verny M, Baumann N.
Les manifestations neurologiques de la maladie de Gaucher de type 1: vers une remise en cause de la classification actuelle? Rev Neurol (Paris) 2006.162(11):1076-1083

Schüpbach WMM, Maltête D, Houeto JL, Tezenas du Montcel S, Mallet L, Welter ML, Gargiulo M, Béhar C, Bonnet AM, Czernecki V, Pidoux B, Navarro S, Dormont D, Cornu P, Agid Y.
Neurosurgery at an earlier stage of Parkinson disease: A randomized controlled trial. Neurology 2007;68(4):267-271

Schüpbach WMM, Welter ML, Bonnet AM, Elbaz A, Grossardt BR, Mesnage V, Houeto JL, Maltête D, Mallet L, Rocca WA, Mallet A, Agid Y.
Mortality in patients with Parkinson’s disease treated by stimulation of the subthalamic nucleus. Mov Disord 2007.22(2):257-261

Schüpbach WMM, Madhavi Vadday K, Schaller A, Brekenfeld C, Kappeler L, Benoist JF, Nguyen-Thi Xuan-Huong C, Burgunder JM, Seibold F, Gallati S, Mattle HP.
MNGIE in three siblings – clinical, genetic and neuroradiological features. J Neurol 2007;254(2):146-153

Schüpbach M, Lohmann E, Anheim M, Lesage S, Czernecki V, Yaici S, Worbe Y, Charles P, Welter ML, Pollak P, Dürr A, Agid Y, Brice A.
Subthalamic nucleus stimulation is efficacious in patients with parkinsonism and LRRK2 mutations. Mov Disord 2007;22(1):119-122

Mallet L, Schüpbach M, N’Diaye K, Rémy P, Bardinet E, Czernecki V, Welter ML, Pelissolo A, Ruberg M, Agid, Y, Yelnik J.
Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc Natl Acad Sci, 2007.104(25):10661-10666

Ben Djebara M, Worbe Y, Schüpbach M, Hartman A.
Aripiprazole: a treatment for severe coprolalia in ‘refractory’ Gilles de la Tourette syndrome. Mov Disord; 2008;23(3):438-40

Schüpbach WMM, Emese B, Loretan P, Mallet A, Duru F, Sanz E, Meier.
Non-invasive Diagnosis of Coronary Artery Disease using Cardiogoniometry Performed at Rest. Swiss Med Wkly 2008.138(15-16):230-238

Czernecki V, Schüpbach M (co-first authorship), Yaici S, Lévy R, Bardinet E, Yelnik J, Dubois B, Agid Y.
Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom. Mov Disord. 2008;23(7):964-969

Voon V, Krack P, Lang AE, Lozano AM, Dujardin K, Schüpbach M, D’Ambrosia J, Thobois S, Tamma F, Herzog J, Speelman JD, Samanta J, Kubu C, Rossignol H, Poon YY, Saint-Cyr JA, Ardouin C, Moro E.
A multicenter study on suicide outcomes following subthalamic stimulation for Parkinson disease. Brain. 2008.131:2720-2728

Schmidt L, d’Arc BF, Lafargue G, Galanaud D, Czernecki V, Grabli D, Schüpbach M, Hartmann A, Lévy R, Dubois B, Pessiglione M.
Disconnecting force from money: effects of basal ganglia damage on incentive motivation. Brain. 2008;131(Pt 5):1303-10

Bardinet E, Bhattacharjee M, Dormont D, Pidoux B, Malandain G, Schüpbach M, Ayache N, Cornu P, Agid Y, Yelnik J.
A three-dimensional, histological and deformable atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation on retrospective series of parkinsonian patients treated by deep brain stimulation. J Neurosurg. 2009;110(2):208-19

Sellner J, Lüthi N, Schüpbach WMM, Gebhardt A, Findling O, Schroth G, Mattle H, Nedeltchev K.
Diagnostic work-up of acute transverse myelitis: spectrum of clinical presentation, neuroimaging and laboratory findings. Spinal Cord. 2009;47(4):312-7

Kraoua I, Stirnemann J, Ribeiro MJ, Rouaud T, Verin M, Annic A, Rose C, Defebvre L Réménieras L, Schüpbach M, Belmatoug N, Vidailhet M, Sedel F.
Parkinsonism in Gaucher disease type 1: 10 new cases and a review of the literature. Mov Disord. 2009;24(10):1524-30

Ardouin C, Chéreau I, Llorca PM, Lhommée E, Durif F, Pollak P
P Krack pour le groupe évaluation comportementale de la maladie de Parkinson. Évaluation des troubles comportementaux hyper- et hypodopaminergiques dans la maladie de Parkinson. Assessment of hyper- and hypodopaminergic behaviors in Parkinson’s disease. Rev Neurol (Paris) 2009;165(11):845-56

Aziz NA, Jurgens CK, Landwehrmeyer GB; EHDN Registry Study Group […, Schüpbach M, …], van Roon-Mom WM, van Ommen GJ, Stijnen T, Roos RA.
Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease. Neurology. 2009;73(16):1280-5

Schüpbach WMM, Corvol JC, Czernecki V, Ben Djebara M, Golmard JL, Agid Y, Hartmann A.
The segmental progression of early untreated Parkinson disease: a novel approach to clinical rating. J Neurol Neurosurg Psychiatry. 2010;81:20-25

Pineau F, Schüpbach M, Corvol JC, Flamand-Rouvière C, Vidailhet M, RozeE.
Long-standing paraphilia induced by dopamine agonists in Parkinson’s disease. Mov Disord 2010;25(7):963-965

Huebner T, Schuepbach WMM, Seeck A, Sanz E, Meier B, Voss A, Pilgram R.
Cardiogoniometric parameters for detection of coronary artery disease at rest as a function of stenosis localization and distribution. Medical & Biological Engineering & Computing 2010;48(5):435-46

Worbe Y, Mallet L, Golmard JL, Béhar C, Durif F, Jalenques I, Damier P, Derkinderen P, Pollak P, Anheim M, Broussolle E, Xie-Brustolin J, Mesnage V, Mondon K, Viallet F, Jedynak P, Ben Djebara M, Schüpbach M, Pelissolo A, Vidailhet M, Agid Y, Houeto JL, Hartmann A.
Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both? PloS ONE, 2010; e12959

Orth M, Handley OJ, Schwenke C, Dunnett SB, Craufurd D, Ho AK, Wild E, Tabrizi SJ, Landwehrmeyer GB; Investigators of the European Huntington’s Disease Network […, Schüpbach M, …],.
Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY. PLoS Curr. 2010;2. pii: RRN1184

Halter J, Schüpbach WMM, Casali C, Elhasid R, Fay K, Hammans S, Illa I, Kappeler L, Krähenbühl S, Lehmann T, Mandel H, Martí R, Mattle H, Orchard K, Savage D, Sue C, Valcarcel D, Gratwohl A, Hirano M.
Allogeneic hematopoietic stem cell transplantation as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): A consensus conference proposal for a standardized approach. Bone Marrow Transplantation 2011;46(3):330-7 

Saft C, Epplen JT, Wieczorek S, Landwehrmeyer GB, Roos RA, de Yebenes JG, Dose M, Tabrizi SJ, Craufurd D; REGISTRY Investigators of the European Huntington’s Disease Network […, Schüpbach M, …], Arning L.
NMDA receptor gene variations as modifiers in Huntington disease: a replication study. PLoS Curr. 2011;3:RRN1247 

Isaias IU, Volkmann J, Kupsch A, Burgunder JM, Ostrem JL, Alterman RL, Mehdorn HM, Schönecker T, Krauss JK, Starr P, Reese E, Kühn AA, Schüpbach WMM, Tagliati M.
Factors predicting protracted improvement after pallidal DBS for primary dystonia : the role of age and disease duration. J Neurol. 2011;258(8):1469-76

Kipfer S, Stephan MA, Schüpbach WMM, Ballinari P, Kaelin-Lang A.
Resting Tremor in Parkinson’s Disease is a Negative Predictor of Levodopa-Induced Dyskinesia . Arch Neurol 2011;68(8):1037-9

Orth M; European Huntington’s Disease Network […, Schüpbach M, …], Handley OJ, Schwenke C, Dunnett S, Wild EJ, Tabrizi SJ, Landwehrmeyer GB. Observing Huntington’s disease: the European Huntington’s Disease Network’s REGISTRY. J
Neurol Neurosurg Psychiatry. 2011;82(12):1409-12

Quarrell OW, Handley O, O’Donovan K, Dumoulin C, Ramos-Arroyo M, Biunno I, Bauer P, Kline M, Landwehrmeyer GB; European Huntington’s Disease Network […, Schüpbach M, …].
Discrepancies in reporting the CAG repeat lengths for Huntington’s disease. Eur J Hum Genet. 2012;20(1):20-6

Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P, Nance M, Ross CA, Margolis RL, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Sequeiros J, Paulsen JS; PREDICT-HD study of the Huntington Study Group (HSG), Landwehrmeyer GB; REGISTRY Investigators of the European Huntington’s Disease Network […, Schüpbach M, …], Myers RH; HD-MAPS Study Group, MacDonald ME, Gusella JF;
COHORT study of the HSG. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology. 2012;78(10):690-5

van Vugt FT, Schüpbach M, Altenmüller, Bardinet E, Yelnik J, Hälbig TD.
Effects of dopaminergic and subthalamic stimulation on musical performance. J Neur Trans, 2013;120(5):755-9

Timmermann L, Schüpbach M, Hertel F, Wolf E, Eleopra R, Franzini A, Servello D, Skogseid IM, Rumia J, Aliaga AS, Barbe MT, Pauls KA, Lin JP, Moro E, Lloyd A, Maarouf M.
A New Rechargeable Device for Deep Brain Stimulation: A Prospective Patient Satisfaction Survey. Eur Neurol. 2013;69(4):193-199

Deuschl G, Schüpbach WMM, Knudsen K, Pinsker MO, Cornu P, Rau J, Agid Y, Schade-Brittinger C.
Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson’s disease: Concept and standards of the EARLYSTIM-study. Parkinsonism Relat Disord. 2013;19(1):56-61

Schuepbach WMM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Hälbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltête D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Krüger R, Pinsker MO, Amtage F, Régis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G for the EARLYSTIM-study group.
Neurostimulation for Parkinson’s Disease with Early Motor Complications. N Engl J Med. 2013;368(7):610-22

Metzger S, Walter C, Riess O, Roos RA, Nielsen JE, Craufurd D, REGISTRY Investigators of the European Huntington’s Disease Network […, Schüpbach M, …], Nguyen HP.
The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients. PLoS One. 2013;8(7):e68951.

Hubers AA, van Duijn E, Roos RA, Craufurd D, Rickards H, Bernhard Landwehrmeyer G, van der Mast RC, Giltay EJ; REGISTRY investigators of the European Huntington’s Disease Network […, Schüpbach M, …].
Suicidal ideation in a European Huntington’s disease population. J Affect Disord. 2013;151(1):248-58.

Welter ML, Schüpbach WMM, Czernecki V, Karachi C, Fernandez-Vidal S, Golmard JL, Serra G, Navarro S, Welaratne A, Hartmann A, Mesnage V, Pineau F, Cornu P, Pidoux B, Worbe Y, Zikos P, Grabli D, Galanaud D, Bonnet AM, Belaid H, Dormont D, Vidailhet M, Mallet L, Houeto JL, Bardinet E, Yelnik J, and Agid Y.
Optimal target localisation for subthalamic stimulation in Parkinson’s disease patients. Neurology. 2014;82(15):1352-61.

Brugger F, Schüpbach M, Koenig M, Müri R, Bohlhalter S, Kaelin-Lang A, Kamm C, Kägi G.
The clinical spectrum of ataxia with oculomotor apraxia type 2. Mov Disord Clin Pract 2014;1(2):106-109

Pollo C, Kaelin-Lang A, Oertel MF, Stieglitz L, Taub E, Fuhr P, Lozano AM, Raabe A, Schüpbach M.
Directional deep brain stimulation: an intraoperative double-blind pilot study. Brain. 2014;137:2015-2026.

Mordasini L, Kessler TM, Kiss B, Schüpbach M, Pollo C, Kaelin-Lang A.
Bladder function in patients with dystonia undergoing deep brain stimulation. Parkinsonism Rel Disord. 2014;20:1015-1017.

Muellner J, Delmaire C, Valabrégue R, Schüpbach M, Mangin JF, Vidailhet M, Lehéricy S, Hartmann A, Worbe Y.
Altered structure of cortical sulci in Gilles de la Tourette syndrome: Further support for abnormal brain development. Mov Disord. 2015;30(5):655-61.

Muellner J, Gharrad I, Habert MO, Kas A, Martini JB, Cormier-Dequaire F, Tahiri K, Vidailhet M, Meier N, Brice A, Schuepbach M, Mallet A, Hartmann A, Corvol JC.
Dopaminergic denervation severity depends on COMT Val158Met polymorphism in Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(5):471-6.

Rieu I, Martinez-Martin P, Pereira B, De Chazeron I, Verhagen Metman L, Jahanshahi M, Ardouin C, Chéreau I, Brefel-Courbon C, Ory-Magne F, Klinger H, Peyrol F, Schupbach M, Dujardin K, Tison F, Houeto JL, Krack P, Durif F.
International validation of a behavioral scale in Parkinson’s disease without dementia. Mov Disord. 2015;30(5):705-13.

Nowacki A, Fiechter M, Fichtner J, Debove I, Lachenmayer L, Schüpbach M, Oertel MF, Wiest R, Pollo C.
Using MDEFT MRI Sequences to Target the GPi in DBS Surgery. PLoS One. 2015 Sep 14;10(9):e0137868. 

Halter JP, Michael W, Schüpbach M (co-first-authorship), Mandel H, Casali C, Orchard K, Collin M, Valcarcel D, Rovelli A, Filosto M, Dotti MT, Marotta G, Pintos G, Barba P, Accarino A, Ferra C, Illa I, Beguin Y, Bakker JA, Boelens JJ, de Coo IF, Fay K, Sue CM, Nachbaur D, Zoller H, Sobreira C, Pinto Simoes B, Hammans SR, Savage D, Martí R, Chinnery PF, Elhasid R, Gratwohl A, Hirano M.
Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy. Brain. 2015;138(Pt 10):2847-58.

Moro E, Schüpbach M, Wächter T, Allert N, Eleopra R, Honey CR, Rueda M, Schiess MC, Shimo Y, Valkovic P, Whone A, Stoevelaar H.
Referring Parkinson’s disease patients for deep brain stimulation: a RAND/UCLA appropriateness study. J 2016;263(1):112-9. 

Cozac VV, Ehrensperger MM, Gschwandtner U, Hatz F, Meyer A, Monsch AU, Schuepbach M, Taub E, Fuhr P.
Older candidates for subthalamic deep brain stimulation in Parkinson’s disease have a higher incidence of psychiatric serious adverse events. Front Aging Neurosci. 2016;8:132.

Hartmann A, Müllner J, Meier N, Hesekamp H, van Meerbeeck P, Habert MO, Kas A, Tanguy ML, Mazmanian M, Oya H, Abuaf N, Gaouar H, Salhi S, Charbonnier-Beaupel F, Fievet MH, Galanaud D, Arguillere S, Roze E, Degos B, Grabli D, Lacomblez L, Hubsch C, Vidailhet M, Bonnet AM, Corvol JC, Schüpbach M.
Bee Venom for the Treatment of Parkinson Disease – A Randomized Controlled Clinical Trial. PLoS One. 2016 Jul 12;11(7):e0158235.

Fundament T, Eldridge PR, Green AL, Whone AL, Taylor RS, Williams AC, Schuepbach WMM.
Deep brain stimulation for Parkinson’s disease with early motor complications: A UK cost-effectiveness analysis. PLoS ONE 2016;11(7);e0159340 

Dams J, Balzer-Geldsetzer M, Siebert U, Deuschl G, Schuepbach WMM, Krack P, Timmermann L, Schnitzler A, Reese JP, Dodel R; EARLYSTIM-investigators.
Cost-effectiveness of neurostimulation in Parkinson’s disease with early motor complications. Mov Disord. 2016;31(8):1183-91.

Shah A, Coste J, Lemaire JJ, Taub E, Schüpbach WMM, Pollo C, Schkommodau E, Guzman R, Hemm-Ode S.
Intraoperative acceleration measurements to qualify improvement in tremor during deep brain stimulation surgery. Med Biol Eng Comput 2016, in press

Lönnfors-Weitzel T, Weitzel T, Slotboom J, Kiefer C, Pollo C, Schüpbach M, Oertel M, Kaelin A, Wiest R.
T2-relaxometry predicts outcome of DBS in idiopathic Parkinson’s disease. NeuroImage: Clinical. 2016;12:832-837. 

Cubo E, Ramos-Arroyo MA, Martinez-Horta S, Martínez-Descalls A, Calvo S, Gil-Polo C; REGISTRY investigators of the European Huntington’s Disease Network […, Schüpbach M, …].
Clinical manifestations of intermediate allele carriers in Huntington disease. Neurology. 2016;87(6):571-8.

Oertel MF, Schüpbach WM, Ghika JA, Stieglitz LH, Fiechter M, Kaelin-Lang A, Raabe A, Pollo C.
Combined thalamic and subthalamic deep brain stimulation for tremor-dominant Parkinson’s disease. Acta Neurochir (Wien). 2017;159(2):265-269.

Review-Artikeln

Schüpbach M. Deszendenz von Niklaus und Elisabeth Schüpbach-Mey;
Ergänzter Stammbaum der Schüpbach von Wyl (Schlosswil); 1989, ergänzt 1991; Schweizerische Landesbibliothek

Schüpbach M. Dissertation (Dr. med.) 1997 s.o.;
Resultate z. T. als Vortrag vorgestellt an der 44. Arbeitstagung des Deutschen Kollegiums für Psychosomatische Medizin (DKPM) in Bern 1996

Schüpbach M, Ranoux D;
Mouvements anormaux psychogènes; Neurologies 2004;7(Spl.7):44-47

Corvol JC, Schüpbach M, Bonnet AM;
Valvulopathies sous pergolide: revue critique de la littérature et conduite à tenir en pratique. Rev Neurol (Paris) 2005;161(6-7):637-643

Agid Y, Schüpbach M, Gargiulo M, Mallet L, Houeto JL, Behar C, Maltête D, Mesnage V, Welter ML.
Neurosurgery in Parkinson’s disease: the doctor is happy, the patient less so? J Neural Transm 2006.Sppl70:409-414

Schüpbach WMM, Agid Y.
Psychosocial adjustment after neurosurgery for Parkinson’s disease. Nat Clin Pract Neurol 2008;4(2):58-59

Reichmann H, Schüpbach WMM.
Pramipexole in the management of Parkinson’s disease. Aging Health 2008;4(3):225-235

Sanz E, Schüpbach M.
Cardiogoniometry: a non-invasive electrocardiographic method to diagnose ischemic heart disease at rest. GMS Medizinische Informatik, Biometrie und Epidemiologie 2009, Vol. 5(3), ISSN 1860-9171

Huebner T, Goernig M, Schuepbach M, Sanz E, Pilgram R, Seeck A, Voss A.
Electrocardiologic and related methods of non-invasive detection and risk stratification in myocardial ischemia: state of the art and perspectives. Ger Med Sci. 2010 Oct 11;8:Doc27

Kaelin-Lang A, Schüpbach M.
Schlaglichter 2010: Neurologie. Schweiz Med Forum 2011;11(3):40-41

Schüpbach WMM.
Impulsivity, impulse control disorders, and subthalamic stimulation in Parkinson’s disease. Basal Ganglia. 2012;2:205-209

Schüpbach WMM.
Functional neurological disorders: from past to present. Swiss Arch Neurol Psychiatry 2012;163(8):279-280.

Ferreira JJ, Katzenschlager R, Bloem BR, Bonuccelli U, Burn D, Deuschl G, Dietrichs E, Fabbrini G, Friedman A, Kanovsky P, Kostic V, Nieuwboer A, Odin P, Poewe W, Rascol O, Sampaio C, Schüpbach M, Tolosa E, Trenkwalder C, Schapira A, Berardelli A, Oertel WH.
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson’s disease. Eur J Neurol. 2013;20(1):5-15

Schüpbach WMM, Rau J, Houeto JL, Krack P, Schnitzler A, Schade-Brittinger C, Timmermann L, Deuschl G.
Myths and facts about the ‚EARLYSTIM‘ study. Mov Disord. 2014;29(14):1742-50.

Bargiotas P, Schuepbach MW, Bassetti CL.
Sleep-wake disturbances in the premotor and early stage of Parkinson’s disease. Curr Opin Neurol. 2016;29(6):763-772.

Eugster L, Bargiotas P, Bassetti CL, Michael Schuepbach WM.
Deep brain stimulation and sleep-wake functions in Parkinson’s disease: A systematic review. Parkinsonism Relat Disord. 2016;32:12-19.

Buchkapitel

Schüpbach WMM.
The long term results of STN stimulation for Parkinson’s disease. Chapter 10; in: Bain P, Aziz T, Liu X., Nandi D. Deep brain stimulation. Oxford University Press; Oxford, New York 2009.

Oertel WH, Berardelli A, Bloem BR, Bonuccelli U, Burn D, Deuschl G, Dietrichs E, Fabbrini G, Ferreira JJ, Friedman A, Kanovsky P, Kostic V, Nieuwboer A, Odin P, Poewe W, Rascol O, Sampaio C, Schüpbach M, Tolosa E, Trenkwalder C.
Early (uncomplicated) Parkinson’s disease. Chapter 14; pg. 217-236 in: European Handbook of Neurological Management: Volume 1, 2^nd Edited by N. E. Gilhus, M. P. Barnes and M. Brainin. 2011 Blackwell Publishing Ltd.

Oertel WH, Berardelli A, Bloem BR, Bonuccelli U, Burn D, Deuschl G, Dietrichs E, Fabbrini G, Ferreira JJ, Friedman A, Kanovsky P, Kostic V, Nieuwboer A, Odin P, Poewe W, Rascol O, Sampaio C, Schüpbach M, Tolosa E, Trenkwalder C.
Late (complicated) Parkinson’s disease. Chapter 15; pg.237-267 in: European Handbook of Neurological Management: Volume 1, 2^nd Edited by N. E. Gilhus, M. P. Barnes and M. Brainin. 2011 Blackwell Publishing Ltd.

Vidailhet M, Schüpbach M, Grabli D.
Pathophysiology and molecular pathology of dystonia and tics. in: Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment; eds.: Albanese A, Jankovic J. 2012 Blackwell Publishing Ltd.